Case for Pharmacotherapy Development for Underactive Bladder

Urology

Volumn 72, Issue 5, 2008, Pages 966-967

  Chancellor, Michael B ^a   Kaufman, Jonathan ^b  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b Frontier Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETHANECHOL; MISOPROSTOL; MUSCARINIC AGENT;

ARTICLE; BLADDER CONTRACTION; BLADDER DISEASE; HUMAN; PRIORITY JOURNAL; UNDERACTIVE BLADDER; UNSPECIFIED SIDE EFFECT;

CHOLINESTERASE INHIBITORS; HUMANS; MISOPROSTOL; MUSCARINIC AGONISTS; URINARY BLADDER DISEASES; URINARY RETENTION;

EID: 54449088706     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.04.041     Document Type: Article

References (6)

1. Ukimura O., Kojima M., Iwata T., et al. Ultrasonic measurement of bladder weight as a novel urodynamic modality. Ad Exper Med Biol. 539 (2003) 311-315
2. Khullar V., Salvatore S., Cardozo L., et al. A novel technique for measuring bladder wall thickness in women using transvaginal ultrasound. Ultrasound Obstet Gynecol. 4 (1994) 220-223
3. Kim J.C., and Park E.Y. Nerve growth factor and prostaglandin E in the urine of female patients with overactive bladder. J Urol. 175 (2006) 1773-1776
4. Yoshimura N., and Chancellor M.B. Differential diagnosis and treatment of impaired bladder emptying. Rev Urol. 6 suppl 1 (2004) S24-S31
5. Kim D.K., Yoshimura N., and Chancellor M.B. A pilot study of AAV1/SERCA2a gene transfer in the rat stress urinary incontinence model. J Urol. 179 (2008) 534-535
6. Rigby D. Underactive bladder syndrome. Nurs Stand 19 (2005) 57-64